Mirae Asset Global Investments
KNSA icon

Mirae Asset Global Investments’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Mirae Asset Global Investments’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Sell
5,982
-8,403
-58% -$436K ﹤0.01% 1028
2026
Q1 		$693K Buy
14,385
+199
+1% +$8.82K ﹤0.01% 886
2025
Q4 		$585K Buy
14,186
+2,485
+21% +$99.7K ﹤0.01% 975
2025
Q3 		$454K Buy
11,701
+10,066
+616% +$327K ﹤0.01% 999
2025
Q2 		$45.8K Buy
1,635
+185
+13% +$4.71K ﹤0.01% 1276
2025
Q1 		$33.5K Buy
1,450
+65
+5% +$1.34K ﹤0.01% 1314
2024
Q4 		$27.7K Sell
1,385
-84
-6% -$1.92K ﹤0.01% 1374
2024
Q3 		$36.7K Buy
1,469
+266
+22% +$6.48K ﹤0.01% 1353
2024
Q2 		$22.4K Sell
1,203
-19,732
-94% -$370K ﹤0.01% 1368
2024
Q1 		$276K Buy
20,935
+1,153
+6% +$22.5K ﹤0.01% 2145
2023
Q4 		$347K Sell
19,782
-1,154
-6% -$19K ﹤0.01% 2140
2023
Q3 		$364K Buy
20,936
+431
+2% +$7.26K ﹤0.01% 2044
2023
Q2 		$290K Sell
20,505
-879
-4% -$11.8K ﹤0.01% 2192
2023
Q1 		$230K Buy
21,384
+4,876
+30% +$64.2K ﹤0.01% 2276
2022
Q4 		$247K Buy
16,508
+3,532
+27% +$51.4K ﹤0.01% 2228
2022
Q3 		$167K Buy
+12,976
New +$148K ﹤0.01% 2394
2021
Q3 		– Sell
-526
Closed -$7K – 1761
2021
Q2 		$7K Buy
+526
New +$7.99K ﹤0.01% 1689

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mirae Asset Global Investments's KNSA Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Kiniksa Pharmaceuticals (KNSA) stake by 58% in Q2 2026, selling an estimated $436K and leaving 5,982 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #1028.

Mirae Asset Global Investments first reported a position in KNSA in Q2 2021 and has held it in 17 quarters since. The position peaked at $693K in Q1 2026. 101 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Mirae Asset Global Investments held 5,982 shares of Kiniksa Pharmaceuticals worth $383K as of Q2 2026.
  • Mirae Asset Global Investments sold 8,403 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $436K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1028 holding.
  • Mirae Asset Global Investments first reported a position in Kiniksa Pharmaceuticals in Q2 2021 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Kiniksa Pharmaceuticals position peaked at $693K in Q1 2026.
  • 101 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.